Skip to main content
. 2017 Aug 18;4:58–65. doi: 10.1016/j.pvr.2017.08.002

Table 1.

Summary of some of the common regulatory mediators in HR-HPV- induced malignancies.

Immunoregulatory factors Main source Mechanisms of immune regulation Possible effect Reference
Arg-1 DCs and other myeloid cells
  • Depletion of arginine

  • Inhibit T cells proliferation and function

[88]
TGF-β & IL-10 Tumor cells, TAM, Treg cells, DCs
  • Modulate DC maturation

  • ↓Overall immune activation

  • Treg cell and regulatory DC differentiation

  • ↓Lymphocyte functions

[91], [93], [94], [95], [96]
IFN-γ Activated T cells
  • ↑IDO and PD-L production

  • ↑Treg function

  • ↓T cell effector function

[88], [89], [95]
PD-L1 Tumor cells, APCs
  • Delivers inhibitory signal to T cells via PD1 receptor molecules

  • ↓T cell activation and proliferation

[75], [93], [130]
PD-1 T cells
  • Delivers intracellular negative signal

  • Induce T cell anergy or exhaustion

[93], [132]
CTLA-4 T cells
  • Competitively inhibit CD80 and CD86 co-stimulatory functions

  • Induce IDO production

  • ↓T cell effector function

[107], [108], [110]
IDO-1 Tumor cells, DCs
  • Depletion of tryptophan

  • ↑ toxic tryptophan metabolites

  • ↑T cell apoptosis

  • ↓T cell effector function

[88], [89], [122], [123], [124]